Gossamer Bio, Inc. (GOSS)
0.4049
+0.02
(+6.13%)
USD |
NASDAQ |
Mar 26, 09:58
Gossamer Bio Free Cash Flow : -171.34M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Vanda Pharmaceuticals, Inc. | -110.44M |
| Madrigal Pharmaceuticals, Inc. | -193.02M |
| Kyntra Bio, Inc. | -4.858M |
| Artelo Biosciences, Inc. | -8.787M |
| Axsome Therapeutics, Inc. | -93.88M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -48.31M |
| Cash from Investing (Quarterly) | 73.16M |
| Cash from Financing (Quarterly) | 3.955M |
| Free Cash Flow Per Share (Quarterly) | -0.2132 |
| Free Cash Flow to Equity (Quarterly) | -48.34M |
| Free Cash Flow to Firm (Quarterly) | -45.57M |
| Free Cash Flow Yield | -186.3% |